Literature DB >> 32122806

Temporal Heterogeneity of Resistance Mechanisms to EGFR-TKI Identified in a Patient With Lung Adenocarcinoma and Sarcomatoid Transformation.

Jinyang Zheng1, Jinfeng Zhu2, Kelian Zhang3, Mingming Yuan4, Mujin Chen2, Rongrong Chen4, Xiaofeng Li5.   

Abstract

Entities:  

Keywords:  Acquired resistance; Epidermal growth factor receptor; Non–small-cell lung cancer; Sarcomatoid transformation; Tumor heterogeneity

Mesh：

Substances：

Year:  2020        PMID： 32122806     DOI： 10.1016/j.cllc.2020.02.003

Source DB:  PubMed          Journal:  Clin Lung Cancer        ISSN： 1525-7304            Impact factor:   4.785


× No keyword cloud information.
  2 in total

1.  Transformation of invasive lung adenocarcinoma with ALK rearrangement into pulmonary sarcomatoid carcinoma.

Authors:  Xianjin Xie; Xudong Chen; Ningning Luo; Yingxue Qi; Mengmeng Li; Xiaoya Feng
Journal:  J Cancer Res Clin Oncol       Date:  2022-04-15       Impact factor: 4.322

2.  Histological Transformation after Acquired Resistance to the Third-Generation EGFR-TKI in Patients with Advanced EGFR-Mutant Lung Adenocarcinoma.

Authors:  Po-Hsin Lee; Yen-Hsiang Huang; Ho Lin; Kuo-Hsuan Hsu; Kun-Chieh Chen; Jeng-Sen Tseng; Gee-Chen Chang; Tsung-Ying Yang
Journal:  Medicina (Kaunas)       Date:  2022-07-08       Impact factor: 2.948
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.